Celgene Corp (CELG) Tops Q3 EPS by 7c, Raises FY11 Guidance Above Street
Tweet
Share
E-mailGet Alerts CELG Hot Sheet
Price: $108.24 --0%
Financial Fact:
Research and development: 1.65B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development: 1.65B
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Celgene Corp (NASDAQ: CELG) reported Q3 EPS of $1.02, $0.07 better than the analyst estimate of $0.95. Revenue for the quarter came in at $1.25 billion versus the consensus estimate of $1.2 billion.
Celgene Corp sees FY2011 EPS of $3.78-$3.80, versus prior guidance of $3.45-$3.55 and the consensus of $3.71. Celgene Corp sees FY2011 revenue of $4.8-$4.85 billion, versus prior guidance of $4.6-$4.7 billion and the consensus of $4.7 billion.
Celgene Corp sees FY2011 EPS of $3.78-$3.80, versus prior guidance of $3.45-$3.55 and the consensus of $3.71. Celgene Corp sees FY2011 revenue of $4.8-$4.85 billion, versus prior guidance of $4.6-$4.7 billion and the consensus of $4.7 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
